Advertisement

Loading...

DRI Healthcare Trust

DHT-U.TOTSX
Healthcare
Drug Manufacturers - Specialty & Generic
$12.20
$-0.05(-0.41%)
Canadian Market opens in 15h 13m

DRI Healthcare Trust Fundamental Analysis

DRI Healthcare Trust (DHT-U.TO) shows moderate financial fundamentals with a PE ratio of -9.73, profit margin of -26.19%, and ROE of -10.60%. The company generates $0.3B in annual revenue with strong year-over-year growth of 17.97%.

Key Strengths

Operating Margin60.13%
PEG Ratio-2.26
Current Ratio1.52

Areas of Concern

ROE-10.60%
We analyze DHT-U.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 4.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
4.7/100

We analyze DHT-U.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

DHT-U.TO struggles to generate sufficient returns from assets.

ROA > 10%
-5.35%

Valuation Score

Excellent

DHT-U.TO trades at attractive valuation levels.

PE < 25
-9.73
PEG Ratio < 2
-2.26

Growth Score

Moderate

DHT-U.TO shows steady but slowing expansion.

Revenue Growth > 5%
17.97%
EPS Growth > 10%
-1.03%

Financial Health Score

Moderate

DHT-U.TO shows balanced financial health with some risks.

Debt/Equity < 1
1.10
Current Ratio > 1
1.52

Profitability Score

Weak

DHT-U.TO struggles to sustain strong margins.

ROE > 15%
-1060.49%
Net Margin ≥ 15%
-26.19%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is DHT-U.TO Expensive or Cheap?

P/E Ratio

DHT-U.TO trades at -9.73 times earnings. This suggests potential undervaluation.

-9.73

PEG Ratio

When adjusting for growth, DHT-U.TO's PEG of -2.26 indicates potential undervaluation.

-2.26

Price to Book

The market values DRI Healthcare Trust at 1.12 times its book value. This may indicate undervaluation.

1.12

EV/EBITDA

Enterprise value stands at 1.50 times EBITDA. This is generally considered low.

1.50

How Well Does DHT-U.TO Make Money?

Net Profit Margin

For every $100 in sales, DRI Healthcare Trust keeps $-26.19 as profit after all expenses.

-26.19%

Operating Margin

Core operations generate 60.13 in profit for every $100 in revenue, before interest and taxes.

60.13%

ROE

Management delivers $-10.60 in profit for every $100 of shareholder equity.

-10.60%

ROA

DRI Healthcare Trust generates $-5.35 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.35%

Following the Money - Real Cash Generation

Operating Cash Flow

DRI Healthcare Trust generates strong operating cash flow of $136.52M, reflecting robust business health.

$136.52M

Free Cash Flow

DRI Healthcare Trust produces free cash flow of $14.43M, offering steady but limited capital for shareholder returns and expansion.

$14.43M

FCF Per Share

Each share generates $0.26 in free cash annually.

$0.26

FCF Yield

DHT-U.TO converts 1.56% of its market value into free cash.

1.56%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-9.73

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-2.26

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.12

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.50

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.10

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.52

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.11

vs 25 benchmark

ROA

Return on assets percentage

-0.05

vs 25 benchmark

ROCE

Return on capital employed

0.13

vs 25 benchmark

How DHT-U.TO Stacks Against Its Sector Peers

MetricDHT-U.TO ValueSector AveragePerformance
P/E Ratio-9.7328.31 Better (Cheaper)
ROE-10.60%699.00% Weak
Net Margin-26.19%-131318.00% (disorted) Weak
Debt/Equity1.100.34 Weak (High Leverage)
Current Ratio1.522775.16 Neutral
ROA-5.35%-14513.00% (disorted) Weak

DHT-U.TO outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews DRI Healthcare Trust's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-50128.14%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ